Cargando…
Small-Molecule Antibiotic Drug Development: Need and Challenges
[Image: see text] The need for new antibiotics is urgent. Antimicrobial resistance is rising, although currently, many more people die from drug-sensitive bacterial infections. The continued evolution of drug resistance is inevitable, fueled by pathogen population size and exposure to antibiotics. A...
Autores principales: | Bergkessel, Megan, Forte, Barbara, Gilbert, Ian H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644355/ https://www.ncbi.nlm.nih.gov/pubmed/37819866 http://dx.doi.org/10.1021/acsinfecdis.3c00189 |
Ejemplares similares
-
Bacterial defenses against a natural antibiotic promote collateral resilience to clinical antibiotics
por: Meirelles, Lucas A., et al.
Publicado: (2021) -
Bacterial transcription during growth arrest
por: Bergkessel, Megan
Publicado: (2021) -
Challenges and Opportunities for Small Molecule Aptamer Development
por: McKeague, Maureen, et al.
Publicado: (2012) -
Discovery of small molecule cancer drugs: Successes, challenges and opportunities
por: Hoelder, Swen, et al.
Publicado: (2012) -
Towards Development of Small Molecule Lipid II Inhibitors as Novel Antibiotics
por: Chauhan, Jamal, et al.
Publicado: (2016)